文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

探索炎症和氧化应激生物标志物与胰腺疾病的关联:一项观察性和孟德尔随机化研究。

Exploring the Associations of Inflammatory and Oxidative Stress Biomarkers with Pancreatic Diseases: An Observational and Mendelian Randomisation Study.

作者信息

Vilà-Quintana Laura, Fort Esther, Pardo Laura, Albiol-Quer Maria T, Ortiz Maria Rosa, Capdevila Montserrat, Feliu Anna, Bahí Anna, Llirós Marc, Aguilar Esther, García-Velasco Adelaida, Ginestà Mireia M, Laquente Berta, Pozas Débora, Lluansí Aleix, Pimenoff Ville Nikolai, Moreno Victor, Garcia-Gil Libadro Jesús, Duell Eric J, Carreras-Torres Robert, Aldeguer Xavier

机构信息

Digestive Diseases and Microbiota Group, Department of Gastroenterology, Girona Biomedical Research Institute (IDIBGI), Hospital Universitari de Girona Dr. Josep Trueta, 17190 Salt, Spain.

General and Digestive Surgery Group, Department of Surgery, Girona Biomedical Research Institute (IDIBGI), Hospital Universitari de Girona Dr. Josep Trueta, 17007 Girona, Spain.

出版信息

J Clin Med. 2024 Apr 12;13(8):2247. doi: 10.3390/jcm13082247.


DOI:10.3390/jcm13082247
PMID:38673519
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11050604/
Abstract

Identifying biomarkers linked to pancreatic ductal adenocarcinoma (PDAC) and chronic pancreatitis (CP) is crucial for early detection, treatment, and prevention. Association analyses of 10 serological biomarkers involved in cell signalling (IFN-γ, IL-6, IL-8, IL-10), oxidative stress (superoxide dismutase (SOD) and glutathione peroxidase (GPx) enzyme activities, total glutathione (GSH), malondialdehyde (MDA) levels), and intestinal permeability proteins (zonulin, I-FABP2) were conducted across PDAC ( = 12), CP ( = 21) and control subjects ( = 23). A Mendelian randomisation (MR) approach was used to assess causality of the identified significant associations in two large genetic cohorts (FinnGen and UK Biobank). Observational results showed a downregulation of SOD and GPx antioxidant enzyme activities in PDAC and CP patients, respectively, and higher MDA levels in CP patients. Logistic regression models revealed significant associations between CP and SOD activity (OR = 0.21, 95% CI [0.05, 0.89], per SD), GPx activity (OR = 0.28, 95% CI [0.10, 0.79], per SD), and MDA levels (OR = 2.05, 95% CI [1.36, 3.08], per SD). MR analyses, however, did not support causality. These findings would not support oxidative stress-related biomarkers as potential targets for pancreatic diseases prevention. Yet, further research is encouraged to assess their viability as non-invasive tools for early diagnosis, particularly in pre-diagnostic CP populations.

摘要

识别与胰腺导管腺癌(PDAC)和慢性胰腺炎(CP)相关的生物标志物对于早期检测、治疗和预防至关重要。对参与细胞信号传导(IFN-γ、IL-6、IL-8、IL-10)、氧化应激(超氧化物歧化酶(SOD)和谷胱甘肽过氧化物酶(GPx)酶活性、总谷胱甘肽(GSH)、丙二醛(MDA)水平)以及肠道通透性蛋白(闭合蛋白、I-FABP2)的10种血清生物标志物进行了关联分析,涉及PDAC患者(n = 12)、CP患者(n = 21)和对照受试者(n = 23)。采用孟德尔随机化(MR)方法在两个大型遗传队列(芬兰基因队列和英国生物银行)中评估已确定的显著关联的因果关系。观察结果显示,PDAC和CP患者的SOD和GPx抗氧化酶活性分别下调,CP患者的MDA水平更高。逻辑回归模型显示CP与SOD活性(OR = 0.21,95%CI [0.05, 0.89],每标准差)、GPx活性(OR = 0.28,95%CI [0.10, 0.79],每标准差)和MDA水平(OR = 2.05,95%CI [1.36, 3.08],每标准差)之间存在显著关联。然而,MR分析不支持因果关系。这些发现不支持将氧化应激相关生物标志物作为预防胰腺疾病的潜在靶点。然而,鼓励进一步研究评估它们作为早期诊断的非侵入性工具的可行性,特别是在诊断前的CP人群中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6077/11050604/e877c1221977/jcm-13-02247-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6077/11050604/43ccd5a3b60c/jcm-13-02247-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6077/11050604/e877c1221977/jcm-13-02247-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6077/11050604/43ccd5a3b60c/jcm-13-02247-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6077/11050604/e877c1221977/jcm-13-02247-g002.jpg

相似文献

[1]
Exploring the Associations of Inflammatory and Oxidative Stress Biomarkers with Pancreatic Diseases: An Observational and Mendelian Randomisation Study.

J Clin Med. 2024-4-12

[2]
Genetically Determined Chronic Low-Grade Inflammation and Hundreds of Health Outcomes in the UK Biobank and the FinnGen Population: A Phenome-Wide Mendelian Randomization Study.

Front Immunol. 2021

[3]
Distinct pathophysiological cytokine profiles for discrimination between autoimmune pancreatitis, chronic pancreatitis, and pancreatic ductal adenocarcinoma.

J Transl Med. 2017-6-2

[4]
Milk consumption and risk of twelve cancers: A large-scale observational and Mendelian randomisation study.

Clin Nutr. 2023-1

[5]
Mendelian randomisation study of the effects of known and putative risk factors on pancreatic cancer.

J Med Genet. 2020-12

[6]
A data-driven approach for studying the role of body mass in multiple diseases: a phenome-wide registry-based case-control study in the UK Biobank.

Lancet Digit Health. 2019-7

[7]
CA 19-9 but Not IGF-1/IGFBP-2 Is a Useful Biomarker for Pancreatic Ductal Adenocarcinoma (PDAC) and Chronic Pancreatitis (CP) Differentiation.

J Clin Med. 2023-6-14

[8]
Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigation.

Int J Cancer. 2018-1-15

[9]
Association of oxidative stress and inflammatory markers with chronic stress in patients with newly diagnosed type 2 diabetes.

Diabetes Metab Res Rev. 2019-3-25

[10]
Oxidative stress and antioxidant enzyme activity in South Indian male smokers with chronic obstructive pulmonary disease.

Respirology. 2013-10

引用本文的文献

[1]
Genetically proxied risk and protective factors for pancreatic cancer: a systematic review and meta-analysis of Mendelian randomization studies.

J Gastrointest Oncol. 2025-6-30

本文引用的文献

[1]
FinnGen provides genetic insights from a well-phenotyped isolated population.

Nature. 2023-1

[2]
Trans-ethnic genome-wide association study of blood metabolites in the Chronic Renal Insufficiency Cohort (CRIC) study.

Kidney Int. 2022-4

[3]
A generalized linear mixed model association tool for biobank-scale data.

Nat Genet. 2021-11

[4]
Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket?

World J Gastroenterol. 2021-7-14

[5]
Biomarkers for assessment of intestinal permeability in clinical practice.

Am J Physiol Gastrointest Liver Physiol. 2021-7-1

[6]
Plasma protein biomarkers for early detection of pancreatic ductal adenocarcinoma.

Int J Cancer. 2021-4-15

[7]
Alterations in Concentration/Activity of Superoxide Dismutases in Context of Obesity and Selected Single Nucleotide Polymorphisms in Genes: , , .

Int J Mol Sci. 2020-7-17

[8]
The microbiome in pancreatic diseases: Recent advances and future perspectives.

United European Gastroenterol J. 2020-10

[9]
Sex differences in the response to oxidative and proteolytic stress.

Redox Biol. 2020-4

[10]
Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors.

World J Oncol. 2019-2

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索